Pear Therapeutics Wins Prix Galien USA Award for Somryst™ as Best Digital Health Product

Pear Therapeutics, Inc. recently announced that the Galien Foundation has awarded the 2020 Prix Galien USA Award for Best Digital Health Product to Somryst™, the first FDA-authorized prescription digital therapeutic (PDT) for patients with chronic insomnia. The award, announced at the Prix Galien USA Awards Virtual Ceremony on October 29, 2020, recognizes companies and individuals who have impacted patient care through innovation.